Senate Subcommittee Hearing on Energy Legislation
January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This hearing serves as a formal legislative review process for 12 specific energy bills, which may influence future federal energy regulations, infrastructure funding, and emission reduction strategies.
Potentially affected actors named in the source documents. Mention is not a position.
U.S. Department of Energy
The agency provides expert testimony and is responsible for implementing policies related to the legislation discussed.
Energy Industry Stakeholders
Various industry groups submitted letters for the record, indicating their interest in how the proposed legislation may impact energy operations.
Last recorded activity January 1, 2021.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on July 9, 2019, in the Dirksen Senate Office Building.
- The Subcommittee reviewed 12 pieces of legislation: S. 143, S. 1685, S. 983, S. 1741, S. 1064, S. 1857, S. 1183, S. 2048, S. 1593, H.R. 1138, S. 1602, and S. 1602.
- The hearing focused on the Department of Energy's role in lowering global emissions through technological innovation.
- Testimony was provided by Bruce J. Walker (Office of Electricity) and Shawn Bennett (Office of Fossil Energy).
- The committee accepted written statements and letters for the record from various organizations, including the American Public Power Association and the National Association of State Energy Officials.
Frequently Asked Questions
What was the purpose of this hearing?
Where can I read the text of the bills discussed?
Why It Matters
This hearing serves as a formal legislative review process for 12 specific energy bills, which may influence future federal energy regulations, infrastructure funding, and emission reduction strategies.
News Coverage
Lobbying Activity
340B Health
2026
“The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); Community Health Center Drug Pricing Protection Act (H.R. 7391); 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; HRSA Rebate Model Pilot pending regulation; Pending Senate "Gang of Six" draft 340B legislation; FY27 Appropriations legislation; Pending introduction of updated and expanded Community Health Center Drug Pricing Protection Act.”
SLOAT HIGGINS JENSENAND ASSOCIATES
on behalf of AMERICAN INTERNATIONAL GROUP
ROSE & KINDEL
on behalf of GLOBAL PHOTON SYSTEMS INC. & ITS SUBSIDIARIES
LAWRENCE J SUFFREDIN
on behalf of AMAZON
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
BRIDGET M O'KEEFE
on behalf of NEW YORK PRIVATE RESIDENCES CONDOMINIUM ASSOCIATION
PAT DOERR
on behalf of HOSPITALITY BUSINESS ASSOC OF CHICAGO
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
JEFFREY A GLASS
on behalf of CITIZENS UTILITY BOARD
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Innovation
The hearing highlights a strategic emphasis on using technological innovation, specifically carbon capture, as the primary mechanism for emission reduction.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools